NR 3-4/2003

get MSIE 4.x or better from www.microsoft.com/ie

Wpływ miejscowo podawanych jodków na wydalanie jodu i funkcję tarczycy

Influence of topically apllied iodides on urinary iodine excretion and thyroid function

Andrzej Stankiewicz, Maksymilian Siekierzyński1, Joanna Wierzbowska

Z Kliniki Okulistycznej Wojskowego Instytutu Medycznego w Warszawie
Kierownik: prof. dr hab. n. med. Andrzej Stankiewicz
1Z Kliniki Endokrynologii Wojskowego Instytutu Medycznego w Warszawie
Kierownik: prof. dr hab. n. med. Maksymilian Siekierzyński

Summary: Purpose: The present study was undertaken, to evaluate whether ophthalmic drug, containing iodine applied to conjunctivall sac might result in a significant increase of urine iodine excretion and thus might be undirectly associated with the risk of iodine-induced hyperthyroidism. The aim of the study was to examine the occurance of biochemically relevant changes in urine iodine excretion and in thyroid function after topical administration of ophthalmic drug containing iodine.
Material and methods: In the study twenty-two patients without a history of thyroid disease were examined. The Vitreolent (Ciba Vision) was applied topically to conjunctival sac four times a day for one month. The urinary iodine excretion, using "Rapid Urinary Iodine Test" (Merck KgaA) and parameters of thyroid function (TSH, FT3 , FT4) were measured before starting and after therapy.
Results: The data showed, that was a significant increase in urinary iodine excretion at the end of therapy; as far as thyroid function was concerned, neither changes in level of TSH nor thyroid hormones were observed.
Słowa kluczowe:  leki okulistyczne zawierające jod, wydalanie jodków z moczem, funkcja tarczycy.
Key words: ophthalmic drugs containing iodine, urinary iodine excretion, thyroid function.



linia-lewa.gif (150 bytes)


Wydawca dwumiesięcznika medycznego "Klinika Oczna"
Oftal Sp. z o.o.

ul. Lindleya4, 02-005 Warszawa
Oddział: 03-709 Warszawa ul. Sierakowskiego 13 (Szpital)

tel./fax: (0-22) 670-47-40
centrala: (0-22) 618-84-85 wew. 52-45

e-mail: ored@okulistyka.com.pl